Urothelial Carcinoma – WHAT NEXT

Urothelial Carcinoma

Bladder Cancer • Urothelial Carcinoma

November 11, 2024 • Views: 7

Drug for Bladder Cancer Earns UK Approval

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) recently issued an approval for BALVERSA (erdafitinib) to treat...

urothelial carcinoma

Bladder Cancer • Urothelial Carcinoma

October 17, 2024 • Views: 31

Padcev Combo Approved in Europe for Adults with Bladder Cancer

Bladder Cancer • Urothelial Carcinoma

July 15, 2024 • Views: 18

The European Union has Approved Bristol Myers Squibb’s OPDIVO for Unresectable or Metastatic Urothelial Carcinoma

bladder cancer, urothelial carcinoma, transitional cell carcinoma

Bladder Cancer • Urothelial Carcinoma

June 20, 2024 • Views: 19

ASCO: PADCEV-Evorpacept Treatment Shows Preliminary Efficacy in Urothelial Cancer

Bladder Cancer • Urothelial Carcinoma

April 25, 2024 • Views: 34

ICYMI: Opdivo Combination Approved for Metastatic Urothelial Carcinoma

Urothelial Carcinoma

July 30, 2024 • Views: 13

Rare Classroom: Metastatic Urothelial Cancer

Urothelial Carcinoma

March 6, 2024 • Views: 35

ICYMI: FDA Approves Balversa (Erdafitinib) for Locally Advanced or Metastatic Urothelial Carcinoma

Urothelial Carcinoma

March 1, 2023 • Views: 636

Rare Classroom: Urothelial Carcinoma

We’re here for everyone who is affected by cancer. We help people find reliable answers to questions about their disease, support, and life beyond cancer.

Let's Work Together

Site Map

Sign up for our weekly summary of articles and conversation.

↑

Close

Rare Black History: A Childhood Home of Rare Disease… August 31, 2023
Study of the Week: New Method for Personalizing Head… April 17, 2023
Mantle Cell Lymphoma: Not Yet Curable, But This… March 1, 2023
New Investigative Therapy Could Drastically Minimize… March 1, 2023
Researchers Develop Deeper Understanding of Acral… May 16, 2023